Additional information
| Active substance | GHRH Peptide |
|---|---|
| Water Retention | Minimal |
| Hepatotoxicity | No significant hepatotoxicity reported |
| Lab Test | Monitoring of IGF-1 levels may be used to assess efficacy |
| Also known as | TH9507 |
| WAREHOUSE | USA Warehouse 5 |
| Blood pressure | Typically no significant impact on blood pressure |
| Trade name | Egrifta |
| Storage conditions | Store in a refrigerator at 2В°C to 8В°C (36В°F to 46В°F) |
| Chemical name | (trans-3-Hexenoyl)lysyl-threonyl-threonyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl-lysyl-threonyl |
| Formula | C221H366N72O67S |
| Substance class | Peptide hormone |
| Main action | Growth hormone-releasing hormone (GHRH) analog |
| Half-life | Approximately 38 minutes |
| Dosage (medical) | 2 mg injected subcutaneously once daily |
| Dosage (sports) | Not applicable as it is not typically used for sports enhancement |
| Effects | Increases natural production of growth hormone |
| Side effects | Injection site reactions (redness, itching, pain), muscle aches, swelling, and potential increase in blood sugar levels |
| Use in sports | Not commonly used due to its specific medical application for reducing excess abdominal fat in HIV-infected patients with lipodystrophy |
| Manufacturer | Ultima Pharmaceuticals – US |
FUCIDIN 500 mg Abdi Ibragim
Bvs Labs Dianabol 10mg 100 Tabletten
Balkan Pharma Turanabol 10 mg 60 Tabletten
Balkan Pharma Strombafort 10 mg 60 Tabletten
Balkan Pharma Clenbuterol 40 mcg 100 Tabletten
Avory Pharma Anavar 10 mg 100 Kapseln
HGH SPECTROS Spectrum Pharma 140iu kit Spectrum Pharmaceuticals 

Reviews
There are no reviews yet.